NettetDescription. Provider of 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing. The … NettetInSphero has raised a total of $35.2M in funding over 9 rounds. Their latest funding was raised on Mar 31, 2024 from a Venture - Series Unknown round. InSphero is funded by 8 investors. ZEISS Ventures and Eurostars are the most recent investors. Funding Rounds. Edit Funding Rounds Section.
INSPHERO - Give your college undergraduate employees a.
NettetInSphero's assay-ready 3D organoids enable life science companies to develop new drugs in a safer, faster, and more efficient way. SCIENCE. Why InSphero? ... manufactured to the highest quality specifications using our 3D Select™ Process in state-of-the-art facilities by our staff of 3D cell culture experts in toxicology, ... NettetAdd Interview. Add Benefits. Glassdoor gives you an inside look at what it's like to work at InSphero, including salaries, reviews, office photos, and more. This is the InSphero … ctfshow web入门 82
InSphero - Overview, News & Competitors ZoomInfo.com
NettetInSphero provides pharmaceutical and biotechnology services. It focuses on industrial-grade, 3D-cell-based assay solutions, and 3D organ-on-a-chip technology. The … Nettet14. feb. 2024 · This group is open for Filipinos, local employees, and OFW's who are aspiring to complete or get a 2nd degree in Bachelor of Science in Business Administration. This group is also composed of the INSPHERO Alumni Association, current candidates, supporters, and partners of INSPHERO. Only members can see who's in … NettetEmployees at InSphero Jan Lichtenberg Transforming 3D drug discovery and safety, CEO of InSphero and Syndya Therapeutics, SLAS Board Member Frauke ... ctfshow web入门 174